Samay

Samay is on a quest to stop the progression of and ultimately prevent respiratory diseases by empowering patients, caregivers/families and clinicians with high quality and actionable health information at home. Backed by NSF and NIH, we have developed a patented acoustic resonance technology that can detect air trapping, an earlier and more sensitive marker of lung dysfunction. This technology has the potential to accurately diagnose and predict deterioration (exacerbations) 4+ days in advance using low-cost, over-the -counter, sensors (100x cheaper)

Medical devices,machine learning,respiratory diseases,copd,and value based care

Samay operates in the Hospitals and health care industry.

Samay's revenue is 11m - 100m

Samay has 51 - 200 employees.